I think I would support that, but it's interesting that the practice recently has been that pharmaceutical companies have pulled their products off the market or made adjustments quite a bit before Health Canada has acted. It's been interesting.
This is, I think, one of the areas that need some studying. It's getting to be quite interesting. Companies will almost react to international reports or will react to the stock market reaction to international reports before they'll actually respond.... They often are acting earlier than Health Canada. The recent incident that comes to my mind is the issue around dosage of cough medicines for children under two, where industry acted very quickly on that.
It's a little bit of a mix, but I think it would be sensible for Health Canada to have the power.